---
title: "Sector Update: Healthcare Stocks Softer Late Afternoon"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285989258.md"
description: "Healthcare stocks declined late Monday, with the NYSE Healthcare Index down 0.3% and the State Street Healthcare Select Sector SPDR ETF down 0.4%. Zoetis shares fell 7.5% after a price target cut by BNP Paribas. Moderna shares dropped 3.7% amid news of early-stage vaccine development. Sonida Senior Living reported a Q1 loss of $2.39 per share, leading to a 3.3% decline in shares. In contrast, Erasca shares rose 3% following a collaboration with Merck for a clinical trial."
datetime: "2026-05-11T19:59:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285989258.md)
  - [en](https://longbridge.com/en/news/285989258.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285989258.md)
---

# Sector Update: Healthcare Stocks Softer Late Afternoon

03:59 PM EDT, 05/11/2026 (MT Newswires) -- Healthcare stocks were lower late Monday afternoon, with the NYSE Healthcare Index down 0.3% and the State Street Healthcare Select Sector SPDR ETF (XLV) declining 0.4%.

The iShares Biotechnology ETF (IBB) was little changed.

In corporate news, Zoetis ( ZTS ) shares fell 7.5% after BNP Paribas cut its price target to $146 from $185, following the company's Q1 results late last week.

Moderna ( MRNA ) has been working on early-stage vaccines targeting hantaviruses, Bloomberg reported Friday, citing a company statement. The research began before recent infections were reported aboard the Dutch-flagged Hondius, the report said. Moderna ( MRNA ) shares fell 3.7%.

Sonida Senior Living ( SNDA ) shares fell 3.3% after the company reported Q1 loss of $2.39 per diluted share, widening from the loss of $0.77 a year earlier. Analysts polled by FactSet expected a loss of $1.53.

Erasca ( ERAS ) entered into a clinical trial collaboration and supply agreement with Merck (MRK) to study its investigational drug ERAS-0015 in combination with Keytruda in patients with RAS-mutant solid tumors. Erasca ( ERAS ) shares rose 3%.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [ZTS.US](https://longbridge.com/en/quote/ZTS.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [SNDA.US](https://longbridge.com/en/quote/SNDA.US.md)
- [ERAS.US](https://longbridge.com/en/quote/ERAS.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BNPQY.US](https://longbridge.com/en/quote/BNPQY.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Assessing Moderna (MRNA) Valuation After Flu Vaccine Data And Hantavirus Program Interest](https://longbridge.com/en/news/286642428.md)
- [Hantavirus: Is there a risk of another pandemic?](https://longbridge.com/en/news/286634066.md)
- [Bernstein Reaffirms Their Hold Rating on Moderna (MRNA)](https://longbridge.com/en/news/286092762.md)
- [Key facts: Moderna shows 26.6% vs flu; hantavirus preclin, no trials](https://longbridge.com/en/news/285820887.md)
- [Sonida Senior Living Launches $250 Million At-The-Market Equity Program With Major Banks](https://longbridge.com/en/news/286822284.md)